|
ASPM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.07480049702258E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.392800E-04 |
| Normal-vs-Stage2 |
9.716000E-02 |
| Normal-vs-Stage3 |
5.73619999999497E-05 |
| Normal-vs-Stage4 |
1.178220E-02 |
| Stage1-vs-Stage2 |
4.947800E-01 |
| Stage1-vs-Stage3 |
7.151000E-04 |
| Stage1-vs-Stage4 |
2.414400E-02 |
| Stage2-vs-Stage3 |
2.382300E-02 |
| Stage2-vs-Stage4 |
4.487600E-02 |
| Stage3-vs-Stage4 |
3.467000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.01080000001342E-07 |
| Normal-vs-AfricanAmerican |
1.656510E-03 |
| Normal-vs-Asian |
7.309700E-02 |
| Caucasian-vs-AfricanAmerican |
5.566800E-01 |
| Caucasian-vs-Asian |
3.055000E-01 |
| AfricanAmerican-vs-Asian |
9.731800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.54280005332441E-09 |
| Normal-vs-Female |
2.559200E-04 |
| Male-vs-Female |
1.780420E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.978100E-03 |
| Normal-vs-Extreme_Weight |
4.43070000000212E-06 |
| Normal-vs-Obese |
5.343100E-03 |
| Normal-vs-Extreme_Obese |
1.126640E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.128000E-02 |
| Normal_Weight-vs-Obese |
6.559400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.243800E-03 |
| Extreme_Weight-vs-Obese |
5.134000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.818300E-03 |
| Obese-vs-Extreme_Obese |
1.119560E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.454100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.72219999769763E-08 |
| Normal-vs-Age(61-80Yrs) |
1.407610E-04 |
| Normal-vs-Age(81-100Yrs) |
4.701900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.162100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.729600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.672000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.772360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.092400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.970800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.50485999999006E-05 |
| Normal-VS-Type2 PRCC |
3.52279999999983E-05 |
| Normal-VS-KIRP CIMP |
1.169640E-02 |
| Normal-VS-Unclassified PRCC |
5.822900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.120400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.483890E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.199900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.464400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.794800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.029500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.028800E-04 |
| Normal-vs-N1 |
7.206000E-04 |
| Normal-vs-N2 |
1.046040E-01 |
| N0-vs-N1 |
4.437800E-03 |
| N0-vs-N2 |
4.118100E-02 |
| N1-vs-N2 |
5.040600E-01 |
|
|
